nicotinamide-beta-riboside and Amyotrophic-Lateral-Sclerosis

nicotinamide-beta-riboside has been researched along with Amyotrophic-Lateral-Sclerosis* in 2 studies

Other Studies

2 other study(ies) available for nicotinamide-beta-riboside and Amyotrophic-Lateral-Sclerosis

ArticleYear
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1
    Molecular neurobiology, 2021, Volume: 58, Issue:4

    Oxidative stress-induced damage is a major mechanism in the pathophysiology of amyotrophic lateral sclerosis (ALS). A recent human clinical trial showed that the combination of nicotinamide riboside (NR) and pterostilbene (PT), molecules with potential to interfere in that mechanism, was efficacious in ALS patients. We examined the effect of these molecules in SOD1

    Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Cytokines; Female; Male; Metabolome; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Motor Activity; Motor Neurons; Mutation; NAD; Nerve Degeneration; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Sirtuin 3; Spinal Cord; Stilbenes; Superoxide Dismutase-1; Survival Analysis

2021
ALSUntangled 42: Elysium health's "basis".
    Amyotrophic lateral sclerosis & frontotemporal degeneration, 2018, Volume: 19, Issue:3-4

    Topics: Adult; Amyotrophic Lateral Sclerosis; Humans; Male; Niacinamide; Pyridinium Compounds; Stilbenes

2018